The last patent held by Zypitamag is expected to expire on 19 January, 2031. This might pave the way for generic versions of the drug to become available for the public.
Zypitamag, containing pitavastatin magnesium, is commonly used for managing high cholesterol and triglycerides. It is available in a tablet form for oral administration.
The drug Zypitamag holds a total of 1 drug patent, none of which have expired. The patent with title 'Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof' is expected to expire last, on the 19th of January, 2031. When patents for the brand-name drug expire, Zypitamag generic could potentially be available. Below are the details of the patent: